Larvol Delta - Neurogenesis-Hypothesis-Evidence-from-Phase-2-Clinical-Trials-of-NA831-for-the-Treatment-of-Alzheimer39s-Disease

traneurocin oral (NA-831) - Biomed Industries

https://www.ctad-alzheimer.com/sites/www.ctad-alzheimer.com/files/medias/documents/Poster-list_July7.pdf

Lloyd TRAN; Fern VU; Zung TRAN

Aug 3, 2026

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next